It is tempting to speculate that at the tumor site, as is thought to be the case during sepsis (4), sTREM-1 may be blocking the function of membrane-bound TREM-1 via its interference with bona fide TREM-1 ligands. This evidence concerns the gene TREM1 and neoplasm.